The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium.
D000109:Acetylcholine / Q000378:metabolism; D000577:Amides / Q000494:pharmacology; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000097:blood / Q000494:pharmacology*; D002802:Cholinesterases / Q000097:blood / Q000378:metabolism*; D003650:Decamethonium Compounds / Q000494:pharmacology*; D003964:Diaphragm / Q000201:enzymology; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D005449:Fluorenes / Q000097:blood / Q000494:pharmacology*; D006651:Histocytochemistry; D006736:Horses; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D051379:Mice; D009132:Muscles / Q000187:drug effects*; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000201:enzymology; D009474:Neurons / Q000187:drug effects*; D009943:Organophosphorus Compounds / Q000494:pharmacology; D010791:Phrenic Nerve / Q000201:enzymology; D000644:Quaternary Ammonium Compounds / Q000097:blood / Q000494:pharmacology*; D051381:Rats; D013390:Succinylcholine / Q000378:metabolism / Q000494:pharmacology*; D013997:Time Factors
D000577:Amides; D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds; D005449:Fluorenes; D009943:Organophosphorus Compounds; D000644:Quaternary Ammonium Compounds; D002802:Cholinesterases; D013390:Succinylcholine; D000109:Acetylcholine